Thoratec heart device to face panel review

11/28/2007 | Forbes

The FDA has asked an outside panel of cardiac experts to review the effectiveness of Thoratec Corp.'s HeartMate II, a mechanical heart pump designed for heart failure patients awaiting transplants, before granting its approval. Analysts expect HeartMate II to receive a favorable review despite not reaching a key effectiveness goal in a company study.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT